Skip to main content

Table 1 Characteristics of the study population

From: Craniofacial and dentoalveolar morphology in individuals with Prader–Willi syndrome: a case-control study

 

PWS

< 12 years (n = 12)

PWS

12–20 years (n = 10)

PWS

> 20 years (n = 20)

Control

< 12 years (n = 66)

Control

12–20 years (n = 69)

Control

> 20 years (n = 54)

Age, mean years (SD)

8.8 (± 2.1)

15.9 (± 2.3)

26.9 (± 6.8)

8.0 (± 1.4)

13.5 (± 2.0)

33.3 (± 1.5)

No. of males/females

5/7

6/4

11/9

19/47

15/54

16/38

Medication

 No. of GH users

11

9

17

0

0

0

 GH treatment duration, mean months (SD)

56.2 (± 21.8)

114.7 (± 51.3)

67.1 (± 54.0)